Regeneron a new buy at HSBC on Eyela HD uptake, cancer therapy catalysts

HSBC has initiated coverage of Regeneron Pharmaceuticals at buy citing the potential for increased Eylea HD (aflibercept) sales next year as well as upcoming catalysts for ...